The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
This initiative, funded by the Innovative Health Initiative Joint Undertaking (IHI JU) with over EUR 38 million, aims to ...
Fact checked by Nick Blackmer Crohn's disease can cause symptoms unrelated to your digestion. Health's Crohn's Disease ...
The leading Crohn's Disease companies such as Janssen, RedHill Biopharma, Amgen, Pfizer, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Abbvie, Mesoblast, Alfasigma, ...
2024 — A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically improve ...
The INTERCEPT study is being funded to the tune of €38 million (nearly $40 million) over the next five years and is described ...
Strictly Come Dancing star Amy Dowden has opened up about the full extent of her Crohn's disease which she has battled for ...
Takeda is serving as the Industry Lead in the newly launched INTERCEPT project to identify predictive biomarkers for Crohn's ...
Takeda and the EU’s Innovative Health Initiative have announced a €‎38m project aimed at improving early intervention in ...
Researchers have uncovered differences in how patients with South Asian and white ethnicity present with inflammatory bowel ...
In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback